Dr. Kent Holtorf

Holtorf Medical Group, Medical Director

  • Dr. Kent Holtorf, M.D., embodies the pinnacle of medical innovation, leading Holtorf Medical
    Group with a visionary approach that has markedly transformed patient care.
    Renowned for integrating advanced peptide and bioregulator therapies, Dr. Holtorf expanded his
    influence through twenty-three affiliate centers and twelve franchises, dramatically improving
    treatments for a range of complex health conditions. His expertise, notably in tick-borne illnesses,
    chronic fatigue syndrome, fibromyalgia, CIRS, MCAS, long-COVID, TBI, PTSD, neurodegenerative
    diseases, complex multisystem illness, and beyond, with a particular focus on peptide and bioregulator
    therapy, immune modulation, hypothyroidism undetectable by standard thyroid function tests,
    hormone optimization, veterans’ health, longevity (biological age reduction), and more, underscores a
    focused dedication to immune modulation, undetectable hypothyroidism, hormone optimization,
    veterans’ health, and pioneering in longevity. Dr. Holtorf's unique methodologies not only define his
    niche but also mark him as a global leader in healthcare innovation.
    Champion for Veterans' Well-being: Central to Dr. Holtorf's mission is a profound dedication to
    enhancing healthcare and patient outcomes, particularly among veterans. Inspired by his personal
    health journey overcoming heart failure due to chronic infections, his innovative treatments offer a
    beacon of hope. Dr. Holtorf’s efforts in peptide therapy and immune modulation have revolutionized
    care for veterans, delivering significant quality-of-life improvements for those facing service-related
    health challenges.
    Influential Educator and Visionary: Dr. Holtorf's impact as an educator and mentor is profound beyond
    his clinical achievements. His commitment to a genuinely evidence-based approach has reshaped
    medical education and practice worldwide. With nearly 100 lectures delivered globally and numerous
    influential publications, Dr. Holtorf continues to challenge medical norms and foster a more inclusive,
    effective healthcare paradigm. His latest work, Mold Illness: The Peptide Protocol for the Rapid
    Treatment of CIRS, exemplifies his leadership in addressing complex medical challenges.
    Media and Research Luminary with a Personal Touch: Dr. Holtorf's approach to medicine is uniquely
    characterized by his humor and wit, making his professional interactions both meaningful and engaging.
    This personal flair, combined with his professional rigor, has garnered him widespread recognition in
    national news and prestigious journals. Dr. Holtorf’s insights into complex diseases and healthcare
    innovation have challenged conventional wisdom and highlighted new directions in endocrinology,
    longevity, and infectious diseases.
    In essence, Dr. Holtorf’s bio vividly encapsulates his professional roles, achievements, and the impactful
    nature of his work, all while conveying the values and personal qualities that underpin his approach to
    medicine. His narrative serves not just as a testament to his professional excellence but also as an
    invitation to understand the dynamic and compassionate individual behind his accomplishments.

  • Discover how Oral Peptides and Bioregulators can Transform Chronic Illness and Enhance Longevity

  • To be announced